Download PDF
Dtsch Med Wochenschr 2013; 138(12): 603-607
DOI: 10.1055/s-0032-1332996
Kommentar | Commentary
Kardiologie
© Georg Thieme Verlag KG Stuttgart · New York

Erste „Advanced Heart Failure Unit“ am Herzzentrum der Universitätsklinik Heidelberg

Beispiel einer integrierten Versorgungsstruktur zur optimierten Behandlung der terminalen HerzinsuffizienzFirst „Advanced Heart Failure Unit“ at the Heart Centre of the University hospital Heidelberg Example for integrated care structures for optimized treatment of terminal heart failure
R. Tschierschke
1   1Innere Medizin III, Kardiologie, Angiologie und Pneumologie, Herzzentrum Heidelberg Universitätsklinikum Heidelberg
,
H. A. Katus
1   1Innere Medizin III, Kardiologie, Angiologie und Pneumologie, Herzzentrum Heidelberg Universitätsklinikum Heidelberg
,
P. W. J. Raake
1   1Innere Medizin III, Kardiologie, Angiologie und Pneumologie, Herzzentrum Heidelberg Universitätsklinikum Heidelberg
› Author Affiliations
Further Information

Publication History

03 December 2012

26 February 2013

Publication Date:
12 March 2013 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

terminale Herzinsuffizienz - Herzinsuffizienz-Wachstation

Keywords

terminal heart failure - advanced heart failure unit
 

  • Literatur

  • 1 Abraham WT, Adams KF, Fonarow GC et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications. J Am Coll Cardiol 2005; 46: 57-64
    CrossrefPubMedGoogle Scholar
  • 2 Bart BA, Goldsmith SR, Lee KL et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012; 67: 2296-2304
    PubMedGoogle Scholar
  • 3 Blomkalns AL, Gibler WB. Development of the chest pain center: rationale, implementation, efficacy, and cost-effectiveness. Prog Cardiovasc Dis 2004; 46: 393-403
    CrossrefPubMedGoogle Scholar
  • 4 Breuckmann F, Post F, Giannitsis E et al. Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung für „Chest-Pain-Units“. Kardiologe 2008; 2: 389-394
    CrossrefPubMedGoogle Scholar
  • 5 Burger AJ, Elkayam U, Neibaur MT et al. Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. Am J Cardiol 2001; 88: 35-39
    PubMedGoogle Scholar
  • 6 Costanzo MR, Guglin ME, Saltzberg MT et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 675-683
    CrossrefPubMedGoogle Scholar
  • 7 Costanzo MR, Saltzberg MT, Jessup M et al. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail 2010; 16: 277-284
    CrossrefPubMedGoogle Scholar
  • 8 De Vroey F, Plein D, Vercauteren S et al. Rescue extracorporeal circulation as bridge to recovery in fulminant cocaine-induced heart failure. Int J Cardiol 2009; 133: e111-113
    CrossrefPubMedGoogle Scholar
  • 9 de Waha S, Desch S, Eitel I et al. What is the evidence for IABP in STEMI with and without cardiogenic shock?. Ther Adv Cardiovasc Dis 2012; 6: 123-132
    CrossrefPubMedGoogle Scholar
  • 10 Post F, Giannitsis E, Riemer T et al. Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the „German chest pain unit registry“. Clin Res Cardiol 2012; 101: 983-991
    CrossrefPubMedGoogle Scholar
  • 11 Gage J, Rutman H, Lucido D et al. Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure. Circulation 1986; 74: 367-373
    CrossrefPubMedGoogle Scholar
  • 12 Hasin Y, Danchin N, Filippatos GS et al. Recommendations for the structure, organization, and operation of intensive cardiac care units. Eur Heart J 2005; 26: 1676-1682
    CrossrefPubMedGoogle Scholar
  • 13 Hertz MI, Aurora P, Christie JD et al. Registry of the International Society for Heart and Lung Transplantation: a quarter century of thoracic transplantation. J Heart Lung Transplant 2008; 27: 937-942
    CrossrefPubMedGoogle Scholar
  • 14 Julian DG. The evolution of the coronary care unit. Cardiovasc Res 2001; 51: 621-624
    CrossrefPubMedGoogle Scholar
  • 15 Kirklin JK, Naftel DC, Kormos RL et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant 2012; 31: 117-126
    CrossrefPubMedGoogle Scholar
  • 16 Kokkinos PF, Choucair W, Graves P et al. Chronic heart failure and exercise. Am Heart J 2000; 140: 21-28
    CrossrefPubMedGoogle Scholar
  • 17 Mager G, Klocke RK, Kux A et al. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure. Am Heart J 1991; 121: 1974-1983
    CrossrefPubMedGoogle Scholar
  • 18 McMurray JJ, Adamopoulos S, Anker SD et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012; 33: 1787-1847
    CrossrefPubMedGoogle Scholar
  • 19 Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81: 1161-1172
    CrossrefPubMedGoogle Scholar
  • 20 Rose EA, Gelijns AC, Moskowitz AJ et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345: 1435-1443
    CrossrefPubMedGoogle Scholar
  • 21 Seyfarth M, Sibbing D, Bauer I et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008; 52: 1584-1588
    CrossrefPubMedGoogle Scholar
  • 22 Sheu JJ, Tsai TH, Lee FY et al. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med 2010; 38: 1810-1817
    CrossrefPubMedGoogle Scholar
  • 23 Slaughter MS, Rogers JG, Milano CA et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241-2251
    CrossrefPubMedGoogle Scholar
  • 24 Slawsky MT, Colucci WS, Gottlieb SS et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 2000; 102: 2222-2227
    CrossrefPubMedGoogle Scholar
  • 25 Statistisches-Bundesamt. Die 20 häufigsten Hauptdiagnosen der vollstationär behandelten Patienten (einschl. Sterbe- und Stundenfälle) nach der International Statistical Classification of Diseases and Related Health Problems (ICD-10) 2010. www.destatis.de 2012;
    PubMedGoogle Scholar
  • 26 Thiele H, Zeymer U, Neumann FJ et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287-1296
    CrossrefPubMedGoogle Scholar